Skip to main content
. Author manuscript; available in PMC: 2025 Sep 27.
Published in final edited form as: Pediatr Infect Dis J. 2025 Sep 10;45(2):e47–e49. doi: 10.1097/INF.0000000000004989

Table 1.

Baseline characteristics of study participants and women living with HIV experiencing pregnancies and factors associated with pregnancy after HIV diagnosis.

WLHIV Total WLHIV experiencing pregnancies Univariate Multivariate
N=498 N=73 OR 95% CI p OR 95% CI p
Median age at ART initiation (yr), median (IQR) 30 (26–36) 27 (24–30)
Age category at ART initiation (yr)
 ≤27 176 (35) 40 (55) 1 1
 >27 322 (65) 33 (45) 0.39 (0.23–0.64) <0.001 0.40 (0.24, 0.67) <0.001
HIV mode of exposure
 Heterosexual contact 473 (95) 72 (99) 1
 Injecting drug use 11 (2) 1 (1) 0.56 (0.07–4.42) 0.580
 Other/Unknown 14 (3) 0 (0) N/A
CD4 (cells/μL) at ART initiation, n (%) 0.077
 ≤50 114 (23) 8 (11) 0.34 (0.15– 0.77) 0.009
 51–100 38 (8) 5 (7) 0.68 (0.25–1.88) 0.460
 101–200 90 (18) 13 (18) 0.76 (0.38–1.53) 0.443
 >200 176 (35) 32 (44) 1
 Not reported 80 (16) 15 (21)
Viral load (copies/mL) at ART initiation, n (%) 0.009 0.010
 ≤50,000 204 (41) 39 (53) 1 1
 50,001–250,000 117 (23) 15 (21) 0.62 (0.33–1.19) 0.149 0.60 (0.31–1.15) 0.126
 >250,000 73 (15) 2 (3) 0.12 (0.03– 0.51) 0.004 0.13 (0.03–0.54) 0.005
 Not done 104 (21) 17 (23)
Ever had a CDC-C diagnosis, n (%)
 No 345 (69) 59 (81) 1
 Yes 152 (31) 14 (19) 0.49 (0.27–0.91) 0.024

CDC-C indicates US Centers for Disease Control and Prevention clinical category C; CI, confidence interval; OR, odds ratio